166 related articles for article (PubMed ID: 35993158)
1. The role of voltage-gated calcium channels in the pathogenesis of Parkinson's disease.
Sandoval A; Duran P; Corzo-López A; Fernández-Gallardo M; Muñoz-Herrera D; Leyva-Leyva M; González-Ramírez R; Felix R
Int J Neurosci; 2024 May; 134(5):452-461. PubMed ID: 35993158
[No Abstract] [Full Text] [Related]
2. The ubiquitin E3 ligase Parkin regulates neuronal Ca
Grimaldo L; Sandoval A; Duran P; Gómez Flores-Ramos L; Felix R
J Neurophysiol; 2022 Dec; 128(6):1555-1564. PubMed ID: 36350063
[TBL] [Abstract][Full Text] [Related]
3. Lower Affinity of Isradipine for L-Type Ca
Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
[TBL] [Abstract][Full Text] [Related]
4. The Role of Voltage-Gated Calcium Channels in Basal Ganglia Neurodegenerative Disorders.
Correa BHM; Moreira CR; Hildebrand ME; Vieira LB
Curr Neuropharmacol; 2023; 21(2):183-201. PubMed ID: 35339179
[TBL] [Abstract][Full Text] [Related]
5. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
6. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
7. Extracellular S100B inhibits A-type voltage-gated potassium currents and increases L-type voltage-gated calcium channel activity in dopaminergic neurons.
Bancroft EA; De La Mora M; Pandey G; Zarate SM; Srinivasan R
Glia; 2022 Dec; 70(12):2330-2347. PubMed ID: 35916350
[TBL] [Abstract][Full Text] [Related]
8. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
Duda J; Pötschke C; Liss B
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
10. The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.
Conway JA; Kinsman G; Kramer ER
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328067
[TBL] [Abstract][Full Text] [Related]
11. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
[TBL] [Abstract][Full Text] [Related]
12. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
[TBL] [Abstract][Full Text] [Related]
13. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
14. Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.
Cha SH; Choi YR; Heo CH; Kang SJ; Joe EH; Jou I; Kim HM; Park SM
Mol Neurodegener; 2015 Dec; 10():63. PubMed ID: 26627850
[TBL] [Abstract][Full Text] [Related]
15. Structure-Function Relationship of the Voltage-Gated Calcium Channel Ca
Wu J; Yan N; Yan Z
Adv Exp Med Biol; 2017; 981():23-39. PubMed ID: 29594856
[TBL] [Abstract][Full Text] [Related]
16. Ca
Filippini L; Ortner NJ; Kaserer T; Striessnig J
Br J Pharmacol; 2023 May; 180(10):1289-1303. PubMed ID: 36788128
[TBL] [Abstract][Full Text] [Related]
17. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Parkin in the ubiquitin proteasome system-mediated degradation of N-type voltage-gated Ca2+ channels.
Grimaldo L; Sandoval A; Garza-López E; Felix R
PLoS One; 2017; 12(9):e0185289. PubMed ID: 28957379
[TBL] [Abstract][Full Text] [Related]
19. Interplay between α-synuclein and parkin genes: Insights of Parkinson's disease.
Sharma K; Chib S; Gupta A; Singh R; Chalotra R
Mol Biol Rep; 2024 Apr; 51(1):586. PubMed ID: 38683365
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins.
Hurley MJ; Brandon B; Gentleman SM; Dexter DT
Brain; 2013 Jul; 136(Pt 7):2077-97. PubMed ID: 23771339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
